These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6804576)

  • 1. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
    Pollack M; Prescott RK
    J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means.
    Cryz SJ; Iglewski BH
    Rev Infect Dis; 1983; 5 Suppl 5():S992-7. PubMed ID: 6419321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics].
    Brodinova NS; Levdikova GA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A: biological, chemical, and immunochemical studies.
    Cryz SJ; Friedman RL; Pavlovskis OR; Iglewski BH
    Infect Immun; 1981 May; 32(2):759-68. PubMed ID: 6265363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
    Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
    Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.
    Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR
    Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
    Klinger KW; Shuster CW
    Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
    Galloway DR; Hedstrom RC; Pavlovskis OR
    Infect Immun; 1984 May; 44(2):262-7. PubMed ID: 6425217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of Pseudomonas aeruginosa exoenzyme S.
    Woods DE; Que JU
    Infect Immun; 1987 Mar; 55(3):579-86. PubMed ID: 3102377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M
    Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY; Tanimoto H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract]   [Full Text] [Related]  

  • 19. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
    Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
    Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.